Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
Eiichiro Nagata,
Mieko Ogino,
Kounosuke Iwamoto,
Yasuhisa Kitagawa,
Yasuo Iwasaki,
Fumihito Yoshii,
Joh-E. Ikeda,
ALS Consortium Investigators
Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients